放射治疗市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

2024年，全球放射治疗市场规模达74亿美元，预估年复合成长率为5.9%，2034年将达130亿美元。这主要得益于癌症治疗，即使用高剂量放射线缩小肿瘤或清除癌细胞。这种疗法的原理是破坏癌细胞的DNA，阻止其分裂和生长。放射治疗主要分为两种：体内放射治疗（又称近距离放射治疗），即将放射性物质置于体内肿瘤附近；体外放射治疗，即使用直线加速器等设备将体外放射线束对准癌细胞。

市场成长主要源自于大众对各种癌症治疗方案（包括放射治疗）认识的提升。许多政府和非营利组织进行宣传活动，向公众宣传早期癌症检测和治疗方案的重要性。此外，调强放射治疗 (IMRT)、影像导引放射治疗 (IGRT) 和质子治疗等技术进步显着提高了放射治疗的精确度，使其能够精准靶向癌细胞，同时保护健康组织。这些创新使放射治疗越来越成为癌症患者的首选治疗方案。

2024年，外束放射治疗市场规模达到48亿美元，预计2034年将以5.9%的复合年增长率持续成长。这一增长主要归因于各种局部癌症的发生率上升，包括乳腺癌、前列腺癌、肺癌和结肠癌。先进质子治疗（一种外束放射治疗）的日益普及，也促进了该市场的扩张。

由于采用直线加速器和质子治疗系统等先进放射治疗技术的普及，医院放射治疗领域在2024年创造了31亿美元的市场规模。医院是癌症治疗的综合中心，提供化疗、免疫疗法和手术等多种疗法。医院与製造商合作开发和应用尖端放射治疗设备，进一步推动了该领域的成长。

受美国癌症发生率上升的推动，美国放射治疗市场在2024年将达到25亿美元。随着癌症确诊人数的不断增加，对先进治疗方案的需求也日益增长，而放射治疗是最有效且应用最广泛的治疗方法之一。人们对放射治疗的有效性及其在治癒性和安宁疗护中的作用的认识不断提高，进一步促进了其应用。

放射治疗市场的知名企业包括 Mevion Medical Systems、Accuray、东芝能源系统及解决方案、Brainlab、三菱电机、IBA Radiopharma Solutions、Isoray Inc.、日立高新技术、RefleXion、Curium、Elekta、佳能医疗系统、Nordion、NTP Radioisotopes 和瓦里安医疗系统。为了巩固市场地位，放射治疗产业的公司正致力于扩大产品组合併提高设备的技术能力。许多市场参与者正在投资开发整合精密成像、即时引导和质子治疗等先进功能的创新放射治疗系统。製造商和医疗机构之间的合作正在加强，以提高治疗中心获得先进技术的可及性。

目录

第一章：方法论与范围

第二章：执行摘要

第三章：行业洞察

• 产业生态系统分析
• 产业衝击力
  • 成长动力
    • 放射治疗技术进步
    • 全球癌症病例不断增加
    • 大众对癌症治疗的认识不断提高
    • 增加医疗基础建设和研发投资
  • 产业陷阱与挑战
    • 发展中和欠发达地区缺乏熟练且经验丰富的医疗保健专业人员
• 成长潜力分析
• 监管格局
• 川普政府关税
  • 对贸易的影响
    • 贸易量中断
    • 各国应对措施
  • 对产业的影响
    • 供应方影响（製造成本）
      • 主要材料价格波动
      • 供应链重组
      • 生产成本影响
    • 需求面影响（消费者成本）
      • 价格传导至终端市场
      • 市占率动态
      • 消费者反应模式
  • 受影响的主要公司
  • 策略产业反应
    • 供应链重组
    • 定价和产品策略
    • 政策参与
  • 展望与未来考虑
• 技术格局
• 未来市场趋势
• 差距分析
• 波特的分析
• PESTEL分析

第四章：竞争格局

• 介绍
• 公司市占率分析
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 策略仪表板

第五章：市场估计与预测：依产品类型，2021 年至 2034 年

• 主要趋势
• 体外放射治疗
  • 调强放射治疗（IMRT）
  • 影像导引放射治疗（IGRT）
  • 质子治疗
  • 其他外部放射疗法
• 内部放射治疗
• 全身放射治疗

第六章：市场估计与预测：按应用，2021 年至 2034 年

• 主要趋势
• 肺癌
• 摄护腺癌
• 乳癌
• 子宫颈癌
• 头颈癌
• 其他应用

第七章：市场估计与预测：依最终用途，2021 年至 2034 年

• 主要趋势
• 医院
• 放射治疗中心及门诊手术中心
• 癌症研究机构

第八章：市场估计与预测：按地区，2021 年至 2034 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
• 拉丁美洲
  • 巴西
  • 墨西哥
• 中东和非洲
  • 沙乌地阿拉伯
  • 南非

第九章：公司简介

• Accuray
• Brainlab
• Curium
• Canon Medical Systems
• Elekta
• Hitachi High-Tech
• IBA Radiopharma Solutions
• Isoray Inc.
• Mevion Medical Systems
• Mitsubishi Electric
• Nordion
• NTP Radioisotopes
• RefleXion
• Toshiba Energy Systems and Solutions
• Varian Medical Systems

The Global Radiotherapy Market was valued at USD 7.4 billion in 2024 and is estimated to grow at a CAGR of 5.9% to reach USD 13 billion by 2034, driven by the treatment for cancer that involves the use of high doses of radiation to shrink tumors or eliminate cancer cells. It works by damaging the DNA of the cancer cells, preventing them from dividing and growing. There are two primary types of radiotherapy: internal, known as brachytherapy, where radioactive material is placed inside the body near the tumor, and external, where an external beam of radiation is directed at the cancer using equipment like linear accelerators.

The market growth is primarily driven by increased public awareness about various cancer treatment options, including radiotherapy. Numerous government and non-profit organizations run awareness campaigns to educate the public on the importance of early cancer detection and treatment options. Additionally, technological advancements such as intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and proton therapy are significantly improving the precision of radiotherapy, allowing for the targeting of cancerous cells while sparing healthy tissues. These innovations are making radiotherapy an increasingly preferred treatment option for cancer patients.

The external beam radiation therapy segment generated USD 4.8 billion in 2024 and is expected to continue its growth at a CAGR of 5.9% through 2034. This growth is mainly attributed to the rising incidence of various types of localized cancers, including breast, prostate, lung, and colon cancers. The increasing adoption of advanced proton therapy, a form of external beam radiotherapy, contributes to the segment's expansion.

The hospital segment generated USD 3.1 billion in 2024 due to the availability of advanced radiotherapy technologies such as linear accelerators and proton therapy systems. Hospitals serve as comprehensive centers for cancer treatment, offering various therapies like chemotherapy, immunotherapy, and surgeries. The collaboration between hospitals and manufacturers to develop and implement cutting-edge radiotherapy equipment has further fueled the segment's growth.

U.S. Radiotherapy Market generated USD 2.5 billion in 2024 driven by the rising cancer incidence across the country. As the number of cancer diagnoses continues to increase, there is a growing demand for advanced treatment options, with radiotherapy being one of the most effective and widely used methods. The increasing awareness of radiotherapy's effectiveness, along with its role in both curative and palliative treatments, has further contributed to its adoption.

Prominent players in the Radiotherapy Market include Mevion Medical Systems, Accuray, Toshiba Energy Systems and Solutions, Brainlab, Mitsubishi Electric, IBA Radiopharma Solutions, Isoray Inc., Hitachi High-Tech, RefleXion, Curium, Elekta, Canon Medical Systems, Nordion, NTP Radioisotopes, Varian Medical Systems. To strengthen their market position, companies operating in the radiotherapy industry are focusing on expanding their product portfolios and improving the technological capabilities of their equipment. Many market players are investing in developing innovative radiotherapy systems that integrate advanced features such as precision imaging, real-time guidance, and proton therapy capabilities. Collaborations between manufacturers and healthcare facilities are rising to improve the accessibility of state-of-the-art technologies in treatment centers.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Technological advancement in radiotherapy
    • 3.2.1.2 Increasing number of cancer cases globally
    • 3.2.1.3 Growing public awareness related to cancer therapy
    • 3.2.1.4 Increasing healthcare infrastructure and R&D investments
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Lack of skilled and experienced healthcare professionals in developing and underdeveloped regions
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Trump administration tariffs
  • 3.5.1 Impact on trade
    • 3.5.1.1 Trade volume disruptions
    • 3.5.1.2 Country-wise response
  • 3.5.2 Impact on the industry
    • 3.5.2.1 Supply-side impact (Cost of manufacturing)
      • 3.5.2.1.1 Price volatility in key materials
      • 3.5.2.1.2 Supply chain restructuring
      • 3.5.2.1.3 Production cost implications
    • 3.5.2.2 Demand-side impact (Cost to consumers)
      • 3.5.2.2.1 Price transmission to end markets
      • 3.5.2.2.2 Market share dynamics
      • 3.5.2.2.3 Consumer response patterns
  • 3.5.3 Key companies impacted
  • 3.5.4 Strategic industry responses
    • 3.5.4.1 Supply chain reconfiguration
    • 3.5.4.2 Pricing and product strategies
    • 3.5.4.3 Policy engagement
  • 3.5.5 Outlook and future considerations
• 3.6 Technological landscape
• 3.7 Future market trends
• 3.8 Gap analysis
• 3.9 Porter's analysis
• 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 – 2034 ($ Mn)

• 5.1 Key trends
• 5.2 External beam radiation therapy
  • 5.2.1 Intensity-modulated radiation therapy (IMRT)
  • 5.2.2 Image-guided radiation therapy (IGRT)
  • 5.2.3 Proton therapy
  • 5.2.4 Other external radiation therapies
• 5.3 Internal radiation therapy
• 5.4 Systemic radiation therapy

Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Lung cancer
• 6.3 Prostate cancer
• 6.4 Breast cancer
• 6.5 Cervical cancer
• 6.6 Head and neck cancer
• 6.7 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Radiotherapy centers and ambulatory surgery centers
• 7.4 Cancer research institutes

Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 India
  • 8.4.3 Japan
  • 8.4.4 Australia
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
• 8.6 Middle East and Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 South Africa

Chapter 9 Company Profiles

• 9.1 Accuray
• 9.2 Brainlab
• 9.3 Curium
• 9.4 Canon Medical Systems
• 9.5 Elekta
• 9.6 Hitachi High-Tech
• 9.7 IBA Radiopharma Solutions
• 9.8 Isoray Inc.
• 9.9 Mevion Medical Systems
• 9.10 Mitsubishi Electric
• 9.11 Nordion
• 9.12 NTP Radioisotopes
• 9.13 RefleXion
• 9.14 Toshiba Energy Systems and Solutions
• 9.15 Varian Medical Systems